6178-44-5

Basic information

• Product Name: Ethyl 3,4,5-trimethoxybenzoate
• Synonyms: RARECHEM AL BI 0063;3,4,5-TRIMETHOXYBENZOIC ACID ETHYL ESTER;ETHYL 3,4,5-TRIMETHOXYBENZOATE;3,4,5-Trimethoxybenzoic;Nsc26825;Benzoic acid, 3,4,5-triMethoxy-, ethyl ester
• CAS NO: 6178-44-5
• Molecular Formula: C₁₂H₁₆O₅
• Molecular Weight: 240.25
• Product Categories: Aromatic Esters
• Mol File: 6178-44-5.mol
• Article Data: 49

Chemical Properties

• Melting Point: 54 °C
• Boiling Point: 168 °C / 6mmHg
• Flash Point: 123.4 °C
• Appearance: /
• Density: 1.113 g/cm³
• Vapor Pressure: 0.00189mmHg at 25°C
• Refractive Index: 1.492
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: Ethyl 3,4,5-trimethoxybenzoate(CAS DataBase Reference)
• NIST Chemistry Reference: Ethyl 3,4,5-trimethoxybenzoate(6178-44-5)
• EPA Substance Registry System: Ethyl 3,4,5-trimethoxybenzoate(6178-44-5)

Safety Data

• Safety Statements: 24/25
• Hazardous Substances Data: 6178-44-5(Hazardous Substances Data)

Usage

General Description

Ethyl 3,4,5-trimethoxybenzoate is a chemical compound categorized under the classification of organic compounds known as benzoic acid esters. These are ester derivatives of benzoic acid. It has a role as a plant metabolite. It contains a benzoate ester as part of its structure and is an aromatic ether with the molecular formula C13H18O5. Ethyl 3,4,5-trimethoxybenzoate is often used in several applications and research fields, although it may require appropriate safety measures due to its chemical properties.

InChI:InChI=1/C12H16O5/c1-5-17-12(13)8-6-9(14-2)11(16-4)10(7-8)15-3/h6-7H,5H2,1-4H3

Upstream product

• 74-83-9 methyl bromide 
• 831-61-8 Ethyl gallate 
• 74-88-4 methyl iodide 
• 64-17-5 ethanol 
• 4521-61-3 3,4,5-Trimethoxybenzoyl chloride 
• 86-81-7 3,4,5-trimethoxy-benzaldehyde 
• 3044-56-2 ethyl trimethoxybenzoyl acetate 
• 78-39-7 Triethyl orthoacetate 
• 118-41-2 Eudesmic acid 
• 1916-07-0 3,4,5-trimethoxybenzoic acid methyl ester 
• 77-78-1 dimethyl sulfate 
• 186581-53-3 diazomethane 

Downstream Products

• 859076-87-2 1-(2,3,4-trimethoxy-phenyl)-3-(3,4,5-trimethoxy-phenyl)-propane-1,3-dione 
• 93199-59-8 1,3-di-(3,4,5-trimethoxyphenyl)-1,3-propanedione 
• 70452-38-9 4-phenyl-1-(3,4,5-trimethoxy-benzoyl)-thiosemicarbazide 
• 18204-69-8 5-(3,4,5-trimetossifenil)-4-fenil-3-carbossimetiltio-4H-1,2,4-triazolo 
• 91759-76-1 [4-Phenyl-5-(3,4,5-trihydroxy-phenyl)-4H-[1,2,4]triazol-3-ylsulfanyl]-acetic acid 
• 70452-56-1 [4-phenyl-5-(3,4,5-trimethoxy-phenyl)-4H-[1,2,4]triazol-3-ylsulfanyl]-acetic acid ethyl ester 
• 70452-47-0 4-phenyl-5-(3,4,5-trimethoxyphenyl)-4H-1,2,4-triazole-3-thiol 
• 39271-75-5 3,4,5-Trimethoxy-benzoic acid [1-(2,6-dichloro-phenyl)-meth-(E)-ylidene]-hydrazide 
• 75921-68-5 1,2,3-trimethoxy-5-(methoxymethyl)benzene 

Relevant articles and documents

Acyl-functionalized molybdenum compounds [(η3-C3H5)(η5-Cp')Mo(CO)2]: An experimental study including the X-ray structure of a rare endo conformer

A series of new acyl-functionalized molybdenum(II) complexes [(η3-C3H5)(η5-C5H4COR)Mo(CO)2] have been successfully synthesized and crystallographically characterized, and the rel

Synthesis of Dithiolethiones and Identification of Potential Neuroprotective Agents via Activation of Nrf2-Driven Antioxidant Enzymes

Oxidative stress is implicated in the pathogenesis of a wide variety of neurodegenerative disorders, and accordingly, dietary supplement of exogenous antioxidants or/and upregulation of the endogenous antioxidant defense system are promising for therapeutic intervention or chemoprevention of neurodegenerative diseases. Nrf2, a master regulator of the cellular antioxidant machinery, cardinally participates in the transcription of cytoprotective genes against oxidative/electrophilic stresses. Herein, we report the synthesis of 59 structurally diverse dithiolethiones and evaluation of their neuroprotection against 6-hydroxydopamine-or H2O2-induced oxidative damages in PC12 cells, a neuron-like rat pheochromocytoma cell line. Initial screening identified compounds 10 and 11 having low cytotoxicity but conferring remarkable protection on PC12 cells from oxidative-mediated damages. Further studies demonstrated that both compounds upregulated a battery of antioxidant genes as well as corresponding genes' products. Significantly, silence of Nrf2 expression abolishes cytoprotection of 10 and 11, indicating targeting Nrf2 activation is pivotal for their cellular functions. Taken together, the two lead compounds discovered here with potent neuroprotective functions against oxidative stress via Nrf2 activation merit further development as therapeutic or chemopreventive candidates for neurodegenerative disorders.

New imidazo[2,1-: B] thiazole-based aryl hydrazones: Unravelling their synthesis and antiproliferative and apoptosis-inducing potential

Herein, we have designed and synthesized new imidazo[2,1-b]thiazole-based aryl hydrazones (9a-w) and evaluated their anti-proliferative potential against a panel of human cancer cell lines. Among the synthesized compounds, 9i and 9m elicited promising cytotoxicity against the breast cancer cell line MDA-MB-231 with IC50 values of 1.65 and 1.12 μM, respectively. Cell cycle analysis revealed that 9i and 9m significantly arrest MDA-MB-231 cells in the G0/G1 phase. In addition, detailed biological studies such as annexin V-FITC/propidium iodide, DCFH-DA, JC-1 and DAPI staining assays revealed that 9i and 9m triggered apoptosis in MDA-MB-213 cells. Overall, the current work demonstrated the cytotoxicity and apoptosis-inducing potential of 9i and 9m in breast cancer cells and suggested that they could be explored as promising antiproliferative leads in the future. This journal is